Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Cancer Discovery|March 3, 2021
At the Heart of Immune Checkpoint Inhibitor-Induced Immune ToxicityArabella Young, Jeffrey A BluestoneFrontiers in Immunology|August 28, 2020
Re-education of the Tumor Microenvironment With Targeted Therapies and ImmunotherapiesShin Foong Ngiow, Arabella YoungCancer Immunology Research|December 5, 2018
The Balancing Act between Cancer Immunity and Autoimmunity in Response to ImmunotherapyArabella Young, Zoe Quandt, Jeffrey A BluestoneImmunological Reviews|August 11, 2023
Stocking the toolbox-Using preclinical models to understand the development and treatment of immune checkpoint inhibitor-induced immune-related adverse eventsMorgan L Cina, Jessica Venegas, Arabella YoungTrends in Immunology|March 14, 2021
Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting CytokinesJee Hye Kang, Jeffrey A Bluestone, Arabella YoungCancer Discovery|July 19, 2014
Targeting cancer-derived adenosine: new therapeutic approachesArabella Young, Deepak Mittal, John Stagg, et al.Journal of the Endocrine Society|September 23, 2020
Breaking β Cell Tolerance After 100 Years of Life: Intratumoral Immunotherapy-Induced Diabetes MellitusZoe Quandt, Catherine Coupe, Mark Anderson, et al.Nature Reviews. Cancer|December 3, 2025
The impact of concomitant medications on treatment outcomes in patients with cancer receiving immune checkpoint inhibitorsSamantha Stone, Jordan P McPherson, Rajan P Kulkarni, et al.Nature Reviews. Cancer|October 24, 2017
Targeting immunosuppressive adenosine in cancerDipti Vijayan, Arabella Young, Michele W L Teng, et al.JAMIA Open|June 15, 2026
irAE.AI: AI-powered exploration of real-world immune-related adverse eventsGabriela Fort, David Stone, Ching-Nung Lin, et al.Pageof 5